Consensus Ardelyx, Inc.

Equities

ARDX

US0396971071

Market Closed - Nasdaq 04:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
6.31 USD -1.87% Intraday chart for Ardelyx, Inc. -2.02% +1.77%

Evolution of the average Target Price on Ardelyx, Inc.

Price target over the last 5 years

History of analyst recommendation changes

cd3d042d51a0ea0975a0b26.dnwqqEZzuOV8GRQHcQjKaFlvlPE8PiMqtGetMchw3mE.MyhvnixD1ZwRTUIyJW-ZARoo27pwUG9ThCjyR7s6jwgQJHDPLBDdvwpxcw~f80b2e12312c622a5d70b96fcd3b3fc9
Wedbush Raises Price Target on Ardelyx to $14 From $13, Keeps Outperform Rating MT
Leerink Partners Initiates Coverage on Ardelyx With Outperform Rating, $14 Price Target MT
Ardelyx Insider Sold Shares Worth $664,978, According to a Recent SEC Filing MT
Wedbush Adjusts Price Target on Ardelyx to $13 From $9, Maintains Outperform Rating MT
Citigroup Raises Price Target on Ardelyx to $14 From $9, Maintains Buy Rating MT
Raymond James Adjusts Ardelyx's Price Target to $15 From $12, Keeps Strong Buy Rating MT
ARDELYX INC: JEFFERIES RAISES TARGET PRICE TO $11 FROM $8… RE
Raymond James Initiates Ardelyx at Strong Buy Rating With $12 Price Target MT
HC Wainwright Raises Price Target on Ardelyx to $11 From $9, Maintains Buy Rating MT
Wedbush Raises Ardelyx's Price Target to $9 From $7, Maintains Outperform Rating MT
HC Wainwright Initiates Coverage on Ardelyx at Buy, $9 Price Target MT
Cantor Fitzgerald Upgrades Ardelyx to Overweight From Neutral, Adjusts Price Target to $10 From $5 MT
Ladenburg Thalmann Adjusts Price Target on Ardelyx to $8.50 From $7.50, Maintains Buy Rating MT
Wedbush Lifts Ardelyx's Price Target to $7 From $6, Keeps Outperform Rating MT
Wedbush Upgrades Ardelyx to Outperform From Neutral, Raises Price Target to $6 From $3 MT
Citigroup Adjusts Ardelyx's Price Target to $7 From $6, Keeps Buy Rating MT
Wedbush Raises Ardelyx's Price Target to $3 From $2, Maintains Neutral Rating MT
Cantor Fitzgerald Adjusts Price Target on Ardelyx to $3 From $1.60, Maintains Neutral Rating MT
Piper Sandler Upgrades Ardelyx to Overweight From Neutral, Adjusts Price Target to $8 From $3 MT
Wedbush Adjusts Price Target on Ardelyx to $2 From $1, Maintains Neutral Rating MT
Piper Sandler Adjusts Price Target on Ardelyx to $3 From $4, Maintains Neutral Rating MT
Cantor Fitzgerald Downgrades Ardelyx to Neutral From Overweight, Adjusts Price Target to $1 From $7 MT
Jefferies Raises Ardelyx to Buy From Hold, Price Target to $5 From $1 MT
Wedbush Adjusts Price Target on Ardelyx to $1 From $2 Following Addition of 'Going Concern' Risk Language in Regulatory Filing; Neutral Rating Kept MT
Ladenburg Thalmann Upgrades Ardelyx to Buy From Neutral; Price Target is $6 MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
6.31 USD
Average target price
13.5 USD
Spread / Average Target
+113.95%
High Price Target
16 USD
Spread / Highest target
+153.57%
Low Price Target
11 USD
Spread / Lowest Target
+74.33%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Ardelyx, Inc.

Wedbush
Leerink Partners
Citigroup
Raymond James
HC Wainwright
Cantor Fitzgerald
Ladenburg Thalmann
Piper Sandler
Jefferies & Co.
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
  1. Stock Market
  2. Equities
  3. ARDX Stock
  4. Consensus Ardelyx, Inc.